Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
The investigation’s state-specific nature suggests potential localized factors, as similar adverse events have not been reported in other regions.
Emergency Medicine February 12th 2025
GoodRx for Healthcare Professionals
Medication-induced ocular complications can occur across multiple drug classes, with risk factors including dosage, duration of treatment, and individual patient susceptibility.
Ophthalmology December 11th 2024
Conexiant
Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.
Allergy & Immunology December 4th 2024
Adverse events from compounded semaglutide have led to hundreds of hospitalizations, highlighting critical safety concerns for healthcare providers managing patients seeking weight loss solutions.
Endocrinology, Diabetes, Metabolism November 20th 2024
Journal of Neurology, Neurosurgery & Psychiatry
CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.
Clinical Pharmacology August 27th 2024
Semaglutide medications, while effective for weight loss, may carry unexpected mental health risks that require careful monitoring and consideration in clinical practice.
Endocrinology, Diabetes, Metabolism August 13th 2024